NCI recognized 11 investigators nationwide with its Cancer Clinical Investigator Team Leadership Awards. The awards support clinical investigators at NCI-designated cancer centers who participate in NCI-funded clinical trials. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. The award provides partial salary support for 2 years for the […]
STAND UP TO CANCER, Cancer Research UK and the Lustgarten Foundation selected members for a Dream Team focused on pancreatic cancer. Daniel Von Hoff, physician-in-chief and distinguished professor at the Translational Genomics Research Institute in Phoenix, chief scientific officer at HonorHealth, and professor of medicine at the Mayo Clinic, will lead the team—with Ronald Evans, […]
NCI awarded eight new, competing and renewed grants as part of its funding for its Specialized Programs of Research Excellence. The grantees will receive $2,185,000 per year for five years.
THE DEATH OF CANCER After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer Is Winnable–and How We Can Get There. By Vincent T. DeVita, Jr. and Elizabeth DeVita-Raeburn; Illustrated. 336 pp. Sarah Crichton Books, Farrar, Strauss & Giroux. $28.00“The Emperor of All Maladies” was a history of oncology, and a good one. “The Death of Cancer” is a memoir of one of the greats of medical oncology. It is a history from someone who was there, making history.
Vincent T. DeVita Jr. has seen the cancer field as a confident young doc eager to challenge the system, as a general in the War on Cancer, as an academic oncologist and, most recently, as a patient.
SRI INTERNATIONAL was awarded a contract of up to $9 million to provide preclinical development services to the NCI PREVENT Cancer Program. Under the contract, SRI will provide scientific expertise, modern testing and support facilities, and analytical instrumentation to conduct a wide variety of preclinical pharmacology and toxicology studies to evaluate potential cancer prevention drugs. […]
CANCERCARE announced the availability of co-payment assistance for pancreatic cancer patients through the CancerCare Co-Payment Assistance Foundation. People receiving assistance from CCAF also have access to the full array of CancerCare services, including counseling, support groups, resource referrals, publications, education and financial assistance with treatment-related expenses such as transportation and child care. “We are thrilled […]
A Boston judge ruled Nov. 3 that Brigham & Women's Hospital had violated the First Amendment rights of a couple who led an aggressive national campaign to stop power morcellation, a surgical procedure routinely used by gynecologists.
THE KNIGHT CANCER INSTITUTE at Oregon Health & Science University launched a program to aid communities statewide in addressing cancer-related needs.
MERCK SERONO awarded its first Grant for Oncology Innovation, who will receive grants totaling EUR 1 million. The grant supports researchers focused on personalized treatment of solid tumors.
